Biomet BMET

  1. All
  2. Commentary
  3. Fund Reports
  4. Headlines
    1. Early results from a study show that Mako Surgincal's (MAKO) robotic arm improves the accuracy of implant placements in knees and reduces pain. The trial is comparing Mako's Restoris implant using ...

      Headlines

      Thu, 21 Mar 2013

      implant placements in knees and reduces pain. The trial is comparing Mako's Restoris implant using the firm's robotic arm with the manual placement of the Oxford Partial Knee implant from Biomet Orthopedics. ( PR ) Post your comment!

    2. Stryker Seems Back On Track, But There's Work To Do

      Headlines

      Thu, 24 Jan 2013

      results were incrementally encouraging. Revenue rose more than 5% this quarter, with organic growth of nearly 6%. Like Biomet and Johnson & Johnson ( JNJ ), Stryker benefited from a recovery in the recon space, as revenue rose more than 6% on

    3. TEXT - S&P comments on Biomet Inc

      Headlines

      Wed, 12 Dec 2012

      12 - Standard & Poor's Ratings Services said today that its ratings on Warsaw, Ind.-based medical products manufacturer Biomet Inc. are not affected by the company's intention to add on $250 million of debt to its existing extended term loan due July

    4. TEXT-S&P rates Biomet's $500 mln senior sub notes 'B-'

      Headlines

      Tue, 18 Sep 2012

      Sept. 18 - Standard & Poor's Ratings Services said today that it assigned Warsaw, Ind.-based medical products manufacturer Biomet Inc.'s $500 million senior subordinated notes maturing 2020 its 'B-'...

    5. BRIEF-Moody's assigns B3 to Biomet senior notes

      Headlines

      Tue, 18 Sep 2012

      Sept 18 (Reuters) - Biomet Inc : * Moody's assigns b3 to biomet 's add-on sr. notes and caa1 to sr. sub notes * Rpt-moody's assigns b3 to biomet 's add-on sr. notes and caa1 to sr. sub notes

    6. Smith & Nephew Increases Dividend, Rewarding Patient Investors Through Weak Growth Phase

      Commentary

      Thu, 2 Aug 2012

      Management made it clear, though, that it would continue evaluating acquisition opportunities. While we think a merger with Biomet remains a compelling option, management previously has expressed an interested in bolt-on acquisitions that would enhance

    7. New Issue- Biomet sells $1 bln notes

      Headlines

      Wed, 25 Jul 2012

      July 25 (Reuters) - Biomet Inc. on Wednesday sold $1 billion of senior notes in the 144a private ..... Fargo were the joint bookrunning managers for the sale. BORROWER: BIOMET AMT $1 BLN COUPON 6.5 PCT MATURITY 08/01/2020 TYPE SR NTS ISS

    8. BRIEF - Moody's rates Biomet amended bank facilities

      Headlines

      Wed, 25 Jul 2012

      July 25 (Reuters) - Moody's assigns B1 to Biomet 's amended bank facilities and B3 to senior unsecured notes, affirms B2 corporate family rating

    9. TEXT-S&P rates Biomet proposed senior notes 'B-'

      Headlines

      Wed, 25 Jul 2012

      that it assigned its 'B-' issue-level and '6' recovery ratings to Warsaw, Ind.-based medical products manufacturer Biomet Inc.'s proposed $550 million senior unsecured notes maturing 2020. The recovery rating reflects our expectation for negligible

    10. TEXT-S&P affirms Biomet Inc ratings

      Headlines

      Wed, 25 Jul 2012

      Overview -- Warsaw, Ind.-based medical products manufacturer Biomet Inc. plans to refinance its existing cash flow revolver, and amend and extend a portion of its term debt. -- We are...

    « Prev12345Next »
    Content Partners